Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
K&f Growth Acquisition II A	KFII	28. mar 2025	9.96	0.00
K&F Growth Acquisition II Unit	KFIIU	28. mar 2025	10.09	0.00
Kadant	KAI	28. mar 2025	335.95	-4.34
Kairos Pharma	KAPA	28. mar 2025	0.92	-5.01
Kaiser Aluminium	KALU	28. mar 2025	62.09	-4.34
Kaival Brands Innovations Group	KAVL	28. mar 2025	0.56	-1.56
Kaixin Holdings	KXIN	28. mar 2025	0.96	+1.46
Kala Bio	KALA	28. mar 2025	6.05	-4.27
Kalaris Therapeutics	KLRS	28. mar 2025	8.60	0.00
Kaltura	KLTR	28. mar 2025	1.94	+1.04
KalVista Pharmaceuticals	KALV	28. mar 2025	11.93	-3.32
Kamada	KMDA	28. mar 2025	6.75	-1.17
Kandi Technologies Group	KNDI	28. mar 2025	1.38	+1.47
Kanzhun ADR	BZ	28. mar 2025	19.46	-2.99
Karat Packaging	KRT	28. mar 2025	27.25	-1.48
Karman	KRMN	28. mar 2025	35.08	0.00
Karooooo	KARO	28. mar 2025	42.66	-0.88
Kartoon Studios	TOON	28. mar 2025	0.60	-0.69
Karyopharm Therapeutics	KPTI	28. mar 2025	4.16	-4.37
Katapult	KPLT	28. mar 2025	11.90	-8.32
Kayne Anderson BDC	KBDC	28. mar 2025	16.51	-1.20
Kayne Anderson Energy Infrastructure Fund	KYN	28. mar 2025	12.92	+0.78
Kazia Therapeutics ADR	KZIA	28. mar 2025	0.88	-7.36
KB Financial Group ADR	KB	28. mar 2025	53.36	-3.21
KB Home	KBH	28. mar 2025	57.73	-2.50
KBR	KBR	28. mar 2025	50.35	-1.62
KBW Bank Powershares	KBWB	28. mar 2025	61.95	-2.44
KBW High Div Yield Financial Powershares	KBWD	28. mar 2025	14.42	-1.77
KBW Prem Yield Equity REIT Powershares	KBWY	28. mar 2025	16.63	-0.36
KBW Prop & Casuality Insur Powershares	KBWP	28. mar 2025	123.32	-0.32

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.